Growth Metrics

Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2016 - 2025)

Zimmer Biomet Holdings has reported Cash from Financing Activities over the past 17 years, most recently at -$897.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$897.0 million for Q4 2025, down 272.82% from a year ago — trailing twelve months through Dec 2025 was $326.0 million (up 167.29% YoY), and the annual figure for FY2025 was $326.0 million, up 167.29%.
  • Cash from Financing Activities for Q4 2025 was -$897.0 million at Zimmer Biomet Holdings, down from $483.8 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ZBH hit a ceiling of $575.4 million in Q1 2025 and a floor of -$897.0 million in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was -$170.0 million (2022), compared with a mean of -$150.2 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 900.23% in 2021 and later surged 1248.5% in 2025.
  • Zimmer Biomet Holdings' Cash from Financing Activities stood at -$655.8 million in 2021, then soared by 52.21% to -$313.4 million in 2022, then rose by 19.78% to -$251.4 million in 2023, then rose by 4.3% to -$240.6 million in 2024, then tumbled by 272.82% to -$897.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$897.0 million (Q4 2025), $483.8 million (Q3 2025), and $163.8 million (Q2 2025) per Business Quant data.